These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27131510)

  • 1. A next-generation proteome array for Schistosoma mansoni.
    de Assis RR; Ludolf F; Nakajima R; Jasinskas A; Oliveira GC; Felgner PL; Gaze ST; Loukas A; LoVerde PT; Bethony JM; Correa-Oliveira R; Calzavara-Silva CE
    Int J Parasitol; 2016 Jun; 46(7):411-5. PubMed ID: 27131510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
    Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
    Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma mansoni: characterization of the gene encoding Sm23, an integral membrane protein.
    Lee KW; Shalaby KA; Medhat AM; Shi H; Yang Q; Karim AM; LoVerde PT
    Exp Parasitol; 1995 Feb; 80(1):155-8. PubMed ID: 7821405
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection.
    Leow CY; Willis C; Leow CH; Hofmann A; Jones M
    Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni Infection of Mice, Rats and Humans Elicits a Strong Antibody Response to a Limited Number of Reduction-Sensitive Epitopes on Five Major Tegumental Membrane Proteins.
    Krautz-Peterson G; Debatis M; Tremblay JM; Oliveira SC; Da'dara AA; Skelly PJ; Shoemaker CB
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005306. PubMed ID: 28095417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational selection of immunodominant and preserved epitope Sm043300e from Schistosoma mansoni and design of a chimeric molecule for biotechnological purposes.
    de Souza C; Lopes MD; De Oliveira FM; Passos MJF; Ferreira LCG; Faria BF; Villar JAFP; Junior MC; Taranto AG; Dos Santos LL; Fonseca CT; de Oliveira Lopes D
    Mol Immunol; 2018 Jan; 93():133-143. PubMed ID: 29175593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to Schistosoma mansoni schistosomula antigens.
    Egesa M; Lubyayi L; Jones FM; van Diepen A; Chalmers IW; Tukahebwa EM; Bagaya BS; Hokke CH; Hoffmann KF; Dunne DW; Elliott AM; Yazdanbakhsh M; Wilson S; Cose S
    Parasite Immunol; 2018 Dec; 40(12):e12591. PubMed ID: 30239012
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant protein from Schistosoma mansoni useful for the detection of S. mansoni and Schistosoma haematobium antibodies.
    Hancock K; Mohamed YB; Haichou X; Noh J; Dotson EM; Tsang VC
    J Parasitol; 1997 Aug; 83(4):612-8. PubMed ID: 9267400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
    Cardoso FC; Pacífico RN; Mortara RA; Oliveira SC
    Clin Exp Immunol; 2006 Jun; 144(3):382-91. PubMed ID: 16734606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.
    Chalmers IW; Fitzsimmons CM; Brown M; Pierrot C; Jones FM; Wawrzyniak JM; Fernandez-Fuentes N; Tukahebwa EM; Dunne DW; Khalife J; Hoffmann KF
    PLoS Negl Trop Dis; 2015; 9(7):e0003920. PubMed ID: 26147973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.
    Farias LP; Cardoso FC; Miyasato PA; Montoya BO; Tararam CA; Roffato HK; Kawano T; Gazzinelli A; Correa-Oliveira R; Coulson PS; Wilson RA; Oliveira SC; Leite LC
    PLoS Negl Trop Dis; 2010 Feb; 4(2):e597. PubMed ID: 20161725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma mansoni Larval Extracellular Vesicle protein 1 (SmLEV1) is an immunogenic antigen found in EVs released from pre-acetabular glands of invading cercariae.
    Gasan TA; Kuipers ME; Roberts GH; Padalino G; Forde-Thomas JE; Wilson S; Wawrzyniak J; Tukahebwa EM; Hoffmann KF; Chalmers IW
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009981. PubMed ID: 34793443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting targets for the diagnosis of Schistosoma mansoni infection: An integrative approach using multi-omic and immunoinformatics data.
    Carvalho GBF; Resende DM; Siqueira LMV; Lopes MD; Lopes DO; Coelho PMZ; Teixeira-Carvalho A; Ruiz JC; Fonseca CT
    PLoS One; 2017; 12(8):e0182299. PubMed ID: 28817585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a vaccine against schistosomiasis using bioinformatics and molecular modeling tools.
    de Oliveira Lopes D; de Oliveira FM; do Vale Coelho IE; de Oliveira Santana KT; Mendonça FC; Taranto AG; dos Santos LL; Miyoshi A; de Carvalho Azevedo VA; Comar M
    Infect Genet Evol; 2013 Dec; 20():83-95. PubMed ID: 23973434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
    PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Schistosoma haematobium and Schistosoma mansoni linear B-cell epitopes with diagnostic potential using in silico immunoinformatic tools and peptide microarray technology.
    Vengesai A; Manuwa M; Midzi H; Mandeya M; Muleya V; Mujeni K; Chipako I; Mduluza T
    PLoS Negl Trop Dis; 2024 Aug; 18(8):e0011887. PubMed ID: 39173089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.